Unmet Needs in Still’s disease
In February 2023, an expert consensus panel of pediatric and adult rheumatologists met to…
View Resource
Osteoarthritis Risky Business (4.18.2025)
Dr. Jack Cush reviews the news and Journal reports from this week on RheumNow.com.…
View Resource
An Epidural Letdown (4.4.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on…
View Resource
1st Line Biologics vs csDMARDs in Adult Still's Disease
A German multicentre, retrospective study assessed the first-line efficacy of biologics and conventional synthetic…
View Resource
ERA, APPs, & Alpha GAL (3.21.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on…
View Resource
World Changers (3.14.2025)
Dr Jack Cush and his podcast friends are out to change the world. Here…
View Resource
The Cartel is Coming for Rheumatology
“What Do Blockbuster Drugs & The Black Market All Have in Common?” asked Dr.…
View Resource
Weak Data (1.24.2025)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. He features Dr.…
View Resource
Lung Involvement in Still's Disease
A multicentre registry observational study assessed lung involvement in a cohort of Still’s disease…
View Resource
Don’t Buy Guitars (12.6.2024)
This year at ACR24, the RheumNow faculty and reporters were prolific, generating >800 Tweets,…
View Resource